On Sep 9, 2021 LEXEO Therapeutics closed a Series B round and raised $100,000,000 from Alexandria Venture Investments, CAM Capital, D1 Capital Partners, Eventide Asset […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series A – Neuroglee Therapeutics
On Sep 9, 2021 Neuroglee Therapeutics closed a Series A round and raised $10,000,000 from EDBI, Eisai, Kuldeep Singh Rajput, Openspace Ventures, Raman Singh, Wendou […]
Series A – PhableCare
On Sep 9, 2021 PhableCare closed a Series A round and raised ₹140,000,000 from Omron Ventures, featuring lead investors Omron Ventures. About the company: PhableCare […]
Series A – DotCom Therapy
On Sep 9, 2021 DotCom Therapy closed a Series A round and raised $8,750,000 from LRVHealth, New Capital Partners, OSF Ventures, featuring lead investors New […]
Series A – Blue Note Therapeutics
On Sep 9, 2021 Blue Note Therapeutics closed a Series A round and raised $5,200,000 from Alumni Ventures Group, Jazz Venture Partners, Memorial Sloan – […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series B – Flo Health
On Sep 9, 2021 Flo Health closed a Series B round and raised $50,000,000 from Target Global, VNV Global, featuring lead investors Target Global, VNV […]
Series A – Replicate Bioscience
On Sep 8, 2021 Replicate Bioscience closed a Series A round and raised $40,000,000 from Apple Tree Partners, featuring lead investors Apple Tree Partners. About […]
Series B – Attralus
On Sep 8, 2021 Attralus closed a Series B round and raised $116,000,000 from Janus Henderson Investors, Logos Capital, Redmile Group, Samsara BioCapital, Sarissa Capital […]
